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Fractionation of the ethyl acetate extract of the bacterium Pseudomonas aeruginosa led to the isolation of five compounds, cyclo–(L-Phe-L-Pro) (1), 3-heptyl-
3-hydroxy-1,2,3,4-tetrahydroquinoline-2.4-dione (2), 2-heptyl-4-hydroxyquinoline (3), 2-nonyl-4-hydroxyquinoline (4), and 1-phenazinecarboxylic acid (5). 
The structures of compounds 1−5 were established by spectroscopic analyses. Compounds 2−4 produced inhibition on the growth of Plasmodium falciparum, 
with IC50 values of 3.47, 2.57 and 2.79 μg/mL, respectively. Compounds 3−4 had activity against Trypanosoma cruzi, with IC50 values of 3.66 and 3.99 
g/mL. Finally, all compounds were found inactive when tested against Leishmania donovani at 10 μg/mL. 
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Pseudomonas aeruginosa is a bacterial species that possess a large 
genome, which allows it to adapt to almost all kinds of ecosystems. 
This broad genome also confers a broad metabolic capacity, 
allowing to produce a wide variety of secondary metabolites [1]. 
There are reports of interesting biomedical activities attributed to 
extracts or compounds isolated from species belonging to the 
Pseudomonas genus, including anticancer, antiparasitic, 
antibacterial and antifungal, among others [1, 2a].  
 
Interestingly, it has been shown that some factors (such as the 
addition of compounds, or co-cultures with other microorganisms) 
modulate the production of certain secondary metabolites in marine 
P. aeruginosa strains. This fact has biotechnological relevance 
because the controlled variation of this kind of factors could allow 
the selective production of certain compounds by P. aeruginosa, 
especially those with antibiotic and antimalarial properties [2b]. 
This work was designed to investigate the potential of a P. 
aeruginosa strain isolated from marine sediments of Panama as a 
source of antiprotozoal compounds. Herein we report the isolation, 
identification and anti-parasitic activity of compounds 1-5 produced 
by P. aeruginosa strain GL0334, isolated from the marine sediment 
collected near Coiba Island, Pacific coast of Panama. This 
bacterium was identified as P. aeruginosa based on the analysis of 
its partial 16S rRNA gene sequences. 
 
P. aeruginosa strain GL0334 was cultured in 10 L of liquid media 
and extracted with ethyl acetate to obtain the organic crude extract. 
The extract was fractionated using C-18 reverse phase solid phase 
extraction cartridges (SPE) followed by HPLC purification to yield 
compounds 1-5. Compounds isolated were identified as cyclo–(L-
Phe-L-Pro) (1), 3-heptyl-3-hydroxy-2,4(1H,3H)-quinolinedione (2), 
2-nonyl-3-hydroxy-4(1H)-quinolinone (3), 2-heptyl-3-hydroxy-4-
quinolone (4), and 1-phenazinecarboxylic acid (5), (Figure 1), by 
spectroscopic analysis including HRESITOF-MS and NMR, and we 
found them to be reported previously in the literature [2c-5]. 
 Figure 1: Compounds isolated from P. aeruginosa strain GL0034. 
 
Table 1: Biological activity (IC50 µg/mL) of compounds isolated from Pseudomonas aeruginosa against Lesihmania donovani, Plasmodium falciparum and Trypanosoma cruzi. 
 
Compounds L. donovani P. falciparum T. cruzi 
1 I I I 
2 I 3.47 I 
3 I 2.57 3.66 
4 I 2.79 3.99 
5                    I I                    I 
chloroquine  0.03  
nifurtimox   1.6 
I = Inactive at 10 µg/mL. 
 
Compounds 1−5 were tested for activity against parasites causative 
of three tropical diseases: Leishmania donovani, Trypanosoma cruzi 
and Plasmodium falciparum. Compounds 2−4 displayed activity 
against P. falciparum, while compounds 3 and 4 were also active 
against T. cruzi (Table 1). Active compounds were less active than 
reference drugs (chloroquine, IC50 = 80–100 nM for P. falciparum, and nifurtimox, IC50 = 0.15–13.4 µM for T. cruzi) for these strains and clone assessed with the same methodology. Regarding toxicity, 
compounds 3-5 have been reported with moderate to weak 
cytotoxicity against cancerous (KB, MCF-7, NCI-H187) and non-
cancerous (Vero) cells [6]. Although there are not previous reports 
about the activity of compounds 1-5 against the strains of parasites 
evaluated in this study, compounds 2-5 were previously tested 
against the K1 multidrug-resistant strain of Plasmodium falciparum 
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[7]. However, that strain has different antimalarial drug-
susceptibility profile and geographical origin than the strain W2 
used in this study. Finally, it is important to point out that 
corresponding tautomers for compounds 3 and 4 showed strong in 
vitro activity against chloroquine sensitive (D6, Sierra Leone) and 
resistant (W2, IndoChina) strains of Plasmodium falciparum by 
measuring plasmodial LDH activity [2b]. This is relevant because it 
confirm that this type of compounds maintains the antimalarial 
activity independently of their tautomeric form. 
 
Experimental 
 
Biological material collection and identification: Sediment sample 
were collected in April 2010 in sterile plastic bags near Coiba 
Island, in the Golf of Chiriquí, Pacific of Panama, by SCUBA 
diving. The sediment sample was suspended in sterile seawater, 
filtered and processed using a standard methodology to obtain the 
bacterial isolates employing a seawater-based nutrient media. Agar 
plates were taken to the laboratory and observed for bacterial 
isolation, at room temperature over the period of one month. Strain 
GL0334 was further isolated from the collection plate and 
successively re-plated until a pure strain was obtained. Taxonomy 
of the strain GL0334 was carried out by sequencing of the 1409 bp 
of 16S rRNA gene. The gene sequence was submitted to NCBI-
BLAST tool and showed 99.7 % similarity to 16S rRNA gene 
sequence of a strain identified as Pseudomonas aeruginosa. 
Sequences are available in GenBank with the accession number 
MK040572. 
 
Fermentation and extraction: The bacterium Pseudomonas 
aeruginosa was inoculated in ten Erlenmeyer flasks (1 L), 
containing 500 mL of seawater-based liquid medium (agar, starch 
of potatoes, yeast extract and peptone). Erlenmeyer flasks were 
placed in an orbital shaker at 172 rpm at room temperature for 10 
days. After this period, the culture broth was extracted with ethyl 
acetate (200 mL x 3). The organic extract was washed with distilled 
water (200 mL x 3) in order to remove traces of culture media from 
the organic extract. The extract was then dried under reduced 
pressure to obtain 456 mg of crude extract. 
 
Isolation of compounds: Extract (202.6 mg) was fractionated using 
C-18 solid phase extraction (SPE) cartridges eluted with a stepwise 
gradient of 20 % (43.8 mg), 40 % (33.8 mg), 50% (7.0 mg), 60 % 
(10.6 mg), 70 % (30.5 mg), 80 % (6.4 mg), 90 % (15.3 mg), and 
100 % (9.5 mg) of methanol in water to yield 8 fractions (F1-F8). 
All the 8 fractions were subjected to antiparasitic assays. Fractions 
C displayed 100% of inhibition of P. falciparum and fraction D 
showed 100% of inhibition of P. falciparum and 78.0% of 
inhibition of T. cruzi. All the fractions were analyzed by means of 
NMR to observe their complexity and it was detected that fraction 
B and E contained a major component. Fraction B eluted with 40% 
of methanol, was purified by reverse phase HPLC (Synergi Hydro-
RP 250 x 10 mm column, isocratic elution of 85% Methanol: 15% 
distilled water, UV detector at 254 nm, flow of 1.0 mL/min) to 
afford 1.3 mg of compound 1. Fraction C eluted with 50% of 
methanol, was purified by reverse phase HPLC (Synergi Hydro-RP 
250 x 10 mm column, isocratic elution of 75% methanol: 25% 
distilled water, UV detector at 254 nm, flow of 1.0 mL/min) to 
afford 0.9 mg compound 2. Fraction D eluted with 60% of 
methanol, was purified by reverse phase HPLC (Synergi Hydro-RP 
250 x 10 mm column, isocratic elution of 75% methanol: 25% 
distilled water, UV detector at 254 nm, flow of 1.0 mL/min) to 
afford 1.2 mg of compound 3, and 1.0 mg of compound 4. Finally, 
Fraction E eluted with 30% of methanol, was purified by reverse 
phase HPLC (Synergi Hydro-RP 250 x 10 mm column, isocratic 
elution of 50% methanol: 50% distilled water, UV detector at 254 
nm, flow of 1.0 mL/min) to afford 1.4 mg of compound 5. 
 
In vitro antiparasitic assays: For L. donovani (amastigotes) and P. 
falciparum (chloroquine-resistant strain, Indochina W2), a DNA 
cross linking agent is used to determine the amount of parasites in 
culture. Positive controls were amphotericin B for L. donovani and 
Chloroquine for P. falciparum [8]. For T. cruzi, a colorimetric 
method was used to determine the inhibition of parasite growth as 
detected by reduction of β-galactosidase (β-Gal) as a reporter gene, 
expressed by the Tulahuen clone C4 of T. cruzi. Nifurtimox was 
used as a positive control [8]. 
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